Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

ABP Insider Trading

Abpro Holdings Inc. | Biological Products, (No Diagnostic Substances)

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Abpro Holdings Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Biological Products, (No Diagnostic Substances) sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2025-08-05 00:22 2025-07-31 Suk Jin Wook (Miles) Director, Officer - CEO and Chairman BUY $0.28 72,035 $20,170 718,512 +11.1%
2025-05-20 03:37 2025-05-19 Suk Jin Wook (Miles) Director, Officer - CEO and Chairman BUY $0.26 16,200 $4,212 146,477 +12.4%
2025-05-01 23:21 2025-04-29 Suk Jin Wook (Miles) Director, Officer - CEO and Chairman BUY $0.25 4,325 $1,081 130,277 +3.4%
2025-04-25 23:58 2025-04-23 Suk Jin Wook (Miles) Director, Officer - CEO and Chairman BUY $0.33 34,002 $11,112 125,902 +37.0%
2008-04-04 19:24 2008-04-02 BURKE FRANKLIN A Director BUY $3.29 50,000 $164,500 2,354,490 +2.2%
2007-12-14 18:36 2007-12-13 BURKE FRANKLIN A Director BUY $3.36 10,000 $33,600 2,303,623 +0.4%
2007-12-13 22:57 2007-12-12 BURKE FRANKLIN A Director BUY $3.46 50,000 $173,000 2,293,623 +2.2%
2007-11-13 17:31 2007-11-12 BURKE FRANKLIN A Director BUY $3.92 60,000 $235,200 2,343,434 +2.6%
2007-11-13 17:17 2007-11-09 BURKE FRANKLIN A Director BUY $4.08 40,592 $165,615 2,283,434 +1.8%
2007-08-17 16:00 2007-08-16 BURKE FRANKLIN A Director BUY $3.63 69,502 $252,292 2,242,011 +3.2%
2007-08-16 16:02 2007-08-15 BURKE FRANKLIN A Director BUY $3.77 9,073 $34,205 2,172,509 +0.4%
2007-08-15 21:52 2007-08-13 BURKE FRANKLIN A Director BUY $3.77 20,900 $78,793 2,163,436 +1.0%
2007-08-14 21:49 2007-08-10 BURKE FRANKLIN A Director BUY $3.69 12,679 $46,786 2,142,536 +0.6%
2007-07-31 21:43 2007-07-26 BURKE FRANKLIN A Director BUY $3.91 42,748 $167,145 2,129,857 +2.0%
2007-07-31 21:42 2007-07-25 BURKE FRANKLIN A Director BUY $3.95 38,356 $151,506 2,087,109 +1.9%
2007-07-31 21:41 2007-07-24 BURKE FRANKLIN A Director BUY $3.98 37,151 $147,861 2,048,753 +1.8%
2007-01-03 17:05 2006-12-29 BURKE FRANKLIN A Director BUY $3.14 20,000 $62,800 2,059,996 +1.0%
2006-11-27 18:56 2006-11-22 BURKE FRANKLIN A Director BUY $3.55 11,200 $39,760 2,039,996 +0.6%
2006-10-04 16:48 2006-10-03 BURKE FRANKLIN A Director BUY $3.01 40,600 $122,206 2,027,970 +2.0%
2006-10-03 17:28 2006-10-02 BURKE FRANKLIN A Director BUY $3.08 37,800 $116,424 1,987,370 +1.9%
2006-10-02 18:04 2006-10-02 WATSON ROBERT L G Officer - CEO/President BUY $3.12 3,000 $9,360 642,695 +0.5%
2006-08-14 17:42 2006-08-11 WAGDA JOSPEH A Director BUY $3.87 2,500 $9,675 1,950 +100.0%
2006-08-14 17:43 2006-08-11 BURKE FRANKLIN A Director BUY $3.82 13,700 $52,334 1,949,570 +0.7%
2006-06-14 17:59 2006-06-14 WATSON ROBERT L G Officer - CEO/President BUY $4.19 10,000 $41,900 639,695 +1.6%
2006-06-02 17:40 2006-05-31 RIGGS RICHARD M Director BUY $4.63 3,000 $13,901 140,563 +2.2%
2006-05-30 17:49 2006-05-25 BARTLETT SCOTT JR Director BUY $4.56 5,000 $22,800 5,000 +100.0%
2006-05-30 17:49 2006-05-25 BURKE FRANKLIN A Director BUY $4.50 21,900 $98,550 1,935,870 +1.1%
2006-03-07 23:35 2006-03-07 WILLIFORD CHRIS E Officer - Executive VP/CFO OPT+S $5.56 20,000 $111,200 36,448 0.0%
2005-12-29 19:24 2005-12-29 WALLACE WILLIAM H Officer - Vice President - Operations OPT+S $5.33 2,000 $10,660 14,416 0.0%
2005-11-22 17:34 2005-11-21 BURKE FRANKLIN A Director BUY $6.45 25,000 $161,250 1,905,970 +1.3%
2005-11-10 19:07 2005-11-10 BURKE FRANKLIN A Director BUY $6.41 18,000 $115,439 1,880,970 +1.0%
2005-11-09 19:04 2005-11-09 BURKE FRANKLIN A Director BUY $6.37 25,000 $159,358 1,862,970 +1.4%
2005-05-20 16:49 2005-05-19 BURKE FRANKLIN A Director BUY $2.34 50,000 $116,850 1,837,970 +2.8%
2005-04-06 17:07 2005-04-06 BURKE FRANKLIN A Director BUY $3.05 19,700 $60,085 1,787,970 +1.1%
2005-04-05 17:46 2005-04-01 BARTLETT SCOTT JR Director SELL $3.17 3,000 $9,516 12,000 -20.0%
2005-04-05 21:04 2005-04-01 BILLINGSLEY LEE T Officer - Vice President - Exploration SELL $3.12 23,415 $73,074 77,940 -23.1%
2005-04-01 18:11 2005-03-30 BARTLETT SCOTT JR Director SELL $2.75 22,000 $60,500 15,000 -59.5%
2005-03-28 22:48 2005-03-24 BURKE FRANKLIN A Director BUY $2.70 5,200 $14,040 1,768,270 +0.3%
2005-03-24 22:21 2005-03-23 BURKE FRANKLIN A Director BUY $2.64 75,100 $197,889 1,763,070 +4.4%
2005-02-11 18:09 2005-02-10 WILLIFORD CHRIS E Officer - Executive VP/CFO OPT+S $2.14 20,000 $42,800 36,448 0.0%
2003-08-12 22:18 2003-07-29 WATSON ROBERT L G Officer - President/CEO/Chairman BUY $0.86 106,977 $92,000 519,632 +25.9%
SHOW ENTRIES

How to Interpret $ABP Trades

Not every insider transaction in Abpro Holdings Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ABP shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for ABP

Insider activity data for Abpro Holdings Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ABP, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.